Literature DB >> 17602892

Interleukin 1-beta (IL-1beta) enhances contractile responses in endothelium-denuded aorta from hypertensive, but not normotensive, rats.

Anne M Dorrance1.   

Abstract

BACKGROUND: The chronic effects of interleukin 1-beta (IL-beta) on vascular reactivity include augmentation of contraction and relaxation. Few studies have assessed the acute effects of IL-1beta in vessels from hypertensive and normotensive rats. We hypothesized that IL-1beta would enhance constriction in aorta from stroke prone spontaneously hypertensive rats (SHRSP).
METHODS: Endothelium denuded aortic rings from 12 week-old SHRSP and Wistar Kyoto (WKY) rats were mounted in a myograph and incubated with IL-1beta (20 ng/ml) for 1 h before construction of a phenylephrine dose response curve. Indomethacin (1 microM) and PP-2 (1 microM) were utilized to inhibit cyclooxygenase (COX) and Src-kinase respectively.
RESULTS: In aorta from SHRSP, IL-1beta caused a significant increase in the force generated over the hour incubation; inhibition of COX or Src-kinase prevented this. The maximum phenylephrine-induced contraction was greater in aorta from SHRSP incubated with IL-1beta than control. COX or Src-kinase inhibition prevented this. IL-1beta had no effect on the vessels from WKY rats.
CONCLUSIONS: These novel data suggest that IL-1beta has rapid effects on vascular smooth muscle from hypertensive rats to produce constriction and to enhance phenylephrine-induced constriction. The COX and Src-kinase pathways appear to be involved in this response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602892      PMCID: PMC2000828          DOI: 10.1016/j.vph.2007.05.007

Source DB:  PubMed          Journal:  Vascul Pharmacol        ISSN: 1537-1891            Impact factor:   5.773


  25 in total

1.  Increased serum levels of interleukin-1beta in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients?

Authors:  G N Dalekos; M Elisaf; E Bairaktari; O Tsolas; K C Siamopoulos
Journal:  J Lab Clin Med       Date:  1997-03

2.  Heme oxygenase-1 attenuates interleukin-1beta-induced nitric oxide synthase expression in vascular smooth muscle cells.

Authors:  Nian-Chung Yang; Liang-Huei Lu; Yung-Hsi Kao; Lee-Young Chau
Journal:  J Biomed Sci       Date:  2004 Nov-Dec       Impact factor: 8.410

3.  Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.

Authors:  A Banes; J A Florian; S W Watts
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

Review 4.  Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells.

Authors:  Wenjuan Shi; Cynthia J Meininger; Tony E Haynes; Kazuyuki Hatakeyama; Guoyao Wu
Journal:  Cell Biochem Biophys       Date:  2004       Impact factor: 2.194

5.  Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1beta: involvement of p38 mitogen-activated protein kinase.

Authors:  S R Bartlett; R Sawdy; G E Mann
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

6.  Effects of tumor necrosis factor and interleukin-1 on the constriction induced by angiotensin II in rat aorta.

Authors:  E Vicaut; C Rasetti; N Baudry
Journal:  J Appl Physiol (1985)       Date:  1996-06

7.  Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation.

Authors:  Ya Jen Chang; Ming Shiang Wu; Jaw Town Lin; Bor Shyang Sheu; Tatsushi Muta; Hiroyasu Inoue; Ching-Chow Chen
Journal:  Mol Pharmacol       Date:  2004-09-29       Impact factor: 4.436

8.  Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone rats independently from blood pressure fall.

Authors:  Luigi Sironi; Paolo Gelosa; Uliano Guerrini; Cristina Banfi; Veronica Crippa; Maura Brioschi; Elisabetta Gianazza; Elena Nobili; Anita Gianella; Marc de Gasparo; Elena Tremoli
Journal:  J Pharmacol Exp Ther       Date:  2004-08-09       Impact factor: 4.030

9.  Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system.

Authors:  David Sanz-Rosa; M Pilar Oubiña; Eva Cediel; Natalia de Las Heras; Onofre Vegazo; Javier Jiménez; Vicente Lahera; Victoria Cachofeiro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-08-12       Impact factor: 4.733

10.  Coupling of c-Src to large conductance voltage- and Ca2+-activated K+ channels as a new mechanism of agonist-induced vasoconstriction.

Authors:  Abderrahmane Alioua; Aman Mahajan; Kazuhide Nishimaru; Masoud M Zarei; Enrico Stefani; Ligia Toro
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  12 in total

1.  Cerebral and skeletal muscle feed artery vasoconstrictor responses in a mouse model with greater large elastic artery stiffness.

Authors:  Ashley E Walker; Elise K Kronquist; Kerrick T Chinen; Kelly D Reihl; Dean Y Li; Lisa A Lesniewski; Anthony J Donato
Journal:  Exp Physiol       Date:  2019-02-03       Impact factor: 2.969

2.  A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Gregory Sprung; Robert Griffiths; Matthew Sparks; Ming Yan; James L Burchette; David N Howell; Eugene E Lin; Benson Okeiyi; Johannes Stegbauer; Yanqiang Yang; Pierre-Louis Tharaux; Phillip Ruiz
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

3.  Lymphocyte responses exacerbate angiotensin II-dependent hypertension.

Authors:  Steven D Crowley; Young-Soo Song; Eugene E Lin; Robert Griffiths; Hyung-Suk Kim; Phillip Ruiz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-02-10       Impact factor: 3.619

Review 4.  Targeting cytokine signaling in salt-sensitive hypertension.

Authors:  Steven D Crowley; Alexander D Jeffs
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

Review 5.  The role of macrophages in hypertension and its complications.

Authors:  A Justin Rucker; Steven D Crowley
Journal:  Pflugers Arch       Date:  2017-03-01       Impact factor: 3.657

Review 6.  Toll-like receptor 4 mediates vascular remodeling in hyperhomocysteinemia.

Authors:  Anastasia Familtseva; Nevena Jeremic; George H Kunkel; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2017-04-06       Impact factor: 3.396

Review 7.  The Future of IL-1 Targeting in Kidney Disease.

Authors:  Baris Afsar; Adrian Covic; Alberto Ortiz; Rengin Elsurer Afsar; Mehmet Kanbay
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

Review 8.  IL-1β and IL-18: inflammatory markers or mediators of hypertension?

Authors:  S M Krishnan; C G Sobey; E Latz; A Mansell; G R Drummond
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia.

Authors:  Katie N Murray; Sylvie Girard; William M Holmes; Laura M Parkes; Stephen R Williams; Adrian R Parry-Jones; Stuart M Allan
Journal:  Stroke       Date:  2014-09-16       Impact factor: 7.914

Review 10.  Vascular Stress Signaling in Hypertension.

Authors:  Stephanie M Cicalese; Josiane Fernandes da Silva; Fernanda Priviero; R Clinton Webb; Satoru Eguchi; Rita C Tostes
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.